Comparison of the Burden of Falls Among Older Adults Aged 70 Years and Over Between Global and China
Xiaodong Chen, Liping Li

TL;DR
This study compares the increasing health impact of falls in older adults globally and in China, projecting continued rises in China.
Contribution
The study provides new projections of fall-related disease burden trends in older adults up to 2030 for both global and Chinese populations.
Findings
China experienced a faster rise in fall incidence rates compared to the global average from 1990 to 2021.
Global fall mortality rates are projected to decline slightly, while China's disability-adjusted life years are expected to increase.
Fall incidence rates are predicted to rise significantly in China by 2030 despite a small decline in mortality rates.
Abstract
To estimate the burden of falls in older adults globally and in China, and project the burden through 2030. Using data from the Global Burden of Disease Study 2021, we calculated age-standardized incidence rate (ASIR), mortality rate (ASMR), and disability-adjusted life years (ASDR) for falls in people aged ≥70 years from 1990 to 2021. Joinpoint regression was used to analyze the trend of falls disease burden during 1990-2021, and Bayesian age-period-cohort (BAPC) modeling was used to predict the trend of falls disease burden in global and China during 2022-2030. From 1990 to 2021, the global burden of falls increased, with AAPCs of 0.60 for ASIR, 0.69 for ASMR, and 0.30 for ASDR. In China, the increase was more pronounced, with AAPCs of 2.44, 1.47, and 0.89, respectively. Projections for 2022-2030 show global ASIR will rise from 7,672.94 to 8,036.87 per 100,000, while ASMR will…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsBalance, Gait, and Falls Prevention · Chronic Disease Management Strategies · Health Systems, Economic Evaluations, Quality of Life
